Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check3 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a small site update. No study information or user-facing content appears to be altered.SummaryDifference0.1%

- Check10 days agoChange DetectedResults posting details were added to the record, indicating that results were posted on 2026-06-16 with associated outcome descriptions and a linked Study Protocol and Statistical Analysis Plan PDF. The reported number of patients with dose modification due to toxicity was updated to 73 (from 75).SummaryDifference2%

- Check17 days agoChange DetectedThe page now signals that recruitment is closed and provides enhanced guidance sections to help readers understand the study details and joining process.SummaryDifference0.5%

- Check24 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This typically reflects minor edits or metadata updates to the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision/version shown on the page was updated from v3.5.3 to v3.5.4, indicating a new release of the document or tool. This change updates the metadata without altering visible content or functionality.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s software/display revision was updated from v3.5.2 to v3.5.3, indicating a minor update to the site version without changing the underlying study details.SummaryDifference0.1%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.